{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:02:29Z","timestamp":1788447749810,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1097\/mpa.0000000000000054","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T14:29:28Z","timestamp":1394548168000},"page":"422-426","source":"Crossref","is-referenced-by-count":5,"title":["Diagnosis of Pernicious Anemia and the Risk of Pancreatic Cancer"],"prefix":"10.1097","volume":"43","author":[{"given":"Pari","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Rhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210212","first-page":"246","article-title":"Risk factors for pancreatic adenocarcinoma and prospects for screening.","volume":"6","author":"Decker","year":"2010","journal-title":"Gastroenterol Hepatol"},{"key":"R2-15-20210212","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/gut.17.7.551","article-title":"Gastric morphology and serum gastrin levels in pernicious anaemia.","volume":"17","author":"Lewin","year":"1976","journal-title":"Gut"},{"key":"R3-15-20210212","first-page":"309","article-title":"Quantitative analysis of gastrin mRNA and peptide in normal and cancerous human pancreas.","volume":"2","author":"Smith","year":"1998","journal-title":"Int J Mol Med"},{"key":"R4-15-20210212","first-page":"R1078","article-title":"Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion.","volume":"270","author":"Smith","year":"1996","journal-title":"Am J Physiol"},{"key":"R5-15-20210212","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00006676-200411000-00005","article-title":"The functional significance of the cholecystokinin-C (CCK-C) receptor in human pancreatic cancer.","volume":"29","author":"Smith","year":"2004","journal-title":"Pancreas"},{"key":"R6-15-20210212","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1200\/JCO.2005.17.954","article-title":"Adjuvant treatment for resectable pancreatic cancer.","volume":"23","author":"Chua","year":"2005","journal-title":"J Clin Oncol"},{"key":"R7-15-20210212","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1097\/MPA.0b013e3181a66fdc","article-title":"Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expression.","volume":"38","author":"Matters","year":"2009","journal-title":"Pancreas"},{"key":"R8-15-20210212","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MPA.0b013e31822ade7e","article-title":"An international multicenter randomized controlled trial of G17DT in patients with pancreatic cancer.","volume":"41","author":"Gilliam","year":"2012","journal-title":"Pancreas"},{"issue":"11","key":"R9-15-20210212","doi-asserted-by":"crossref","first-page":"G1244","DOI":"10.1152\/ajpgi.00460.2011","article-title":"Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis.","volume":"302","author":"Fino","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R10-15-20210212","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0016-5085(03)00697-8","article-title":"Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue.","volume":"125","author":"Reubi","year":"2003","journal-title":"Gastroenterology"},{"issue":"6","key":"R11-15-20210212","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3748\/wjg.v11.i6.803","article-title":"Presence of CCK A, B receptors and effect of gastric and cholecystokinin on growth of pancreatobiliary cancer cell lines.","volume":"11","author":"Jang","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"7","key":"R12-15-20210212","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1080\/003655201300192003","article-title":"Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines.","volume":"36","author":"Monstein","year":"2001","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"R13-15-20210212","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/1097-0142(19930201)71:3<745::AID-CNCR2820710316>3.0.CO;2-1","article-title":"Pernicious anemia and subsequent cancer: a population based cohort study.","volume":"71","author":"Hsing","year":"1993","journal-title":"Cancer"},{"key":"R14-15-20210212","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/BF01655502","article-title":"Increased incidence of pancreatic neoplasia in pernicious anemia.","volume":"12","author":"Borch","year":"1988","journal-title":"World J Surg"},{"key":"R15-15-20210212","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pds.1688","article-title":"The importance of defining periods of complete mortality reporting for research using automated data from primary care.","volume":"18","author":"Maguire","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R16-15-20210212","first-page":"171","article-title":"Feasibility study and methodology to create a quality-evaluated database of primary care data.","volume":"12","author":"Bourke","year":"2004","journal-title":"Inform Prim Care"},{"key":"R17-15-20210212","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research.","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Safe"},{"key":"R18-15-20210212","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/pds.1774","article-title":"Cancer incidence in The Health Improvement Network.","volume":"18","author":"Haynes","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-15-20210212","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MPA.0b013e31822ca176","article-title":"Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from china.","volume":"41","author":"Ben","year":"2012","journal-title":"Pancreas"},{"issue":"suppl 2","key":"R20-15-20210212","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1440-1746.2011.07013.x","article-title":"Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell.","volume":"27","author":"Pandol","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R21-15-20210212","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"The impact of confounder selection criteria on effect estimation.","volume":"129","author":"Mickey","year":"1989","journal-title":"Am J Epidemiol"},{"key":"R22-15-20210212","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.1115","article-title":"The relationship between time since registration and measured incidence rates in the General Practice Research Database.","volume":"14","author":"Lewis","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"R24-15-20210212","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/bjc.1996.195","article-title":"Pernicious anaemia and cancer risk in Denmark.","volume":"73","author":"Mellemkjaer","year":"1996","journal-title":"Br J Cancer"},{"issue":"5","key":"R25-15-20210212","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/bjc.1989.169","article-title":"Cancer risk following pernicious anaemia.","volume":"59","author":"Brinton","year":"1989","journal-title":"Br J Cancer"},{"issue":"8","key":"R26-15-20210212","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/003655200750023228","article-title":"Cancer of the upper gastrointestinal tract among patients with pernicious anemia: a case-cohort study.","volume":"35","author":"Karlson","year":"2000","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"R27-15-20210212","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1007\/s10620-006-9419-3","article-title":"Chronic hypergastrinemia: causes and consequences.","volume":"52","author":"Orlando","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"3","key":"R28-15-20210212","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2036.1987.tb00622.x","article-title":"Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia.","volume":"1","author":"Lanzon Miller","year":"1987","journal-title":"Aliment Pharmacol Ther"},{"key":"R29-15-20210212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/bjc.2011.511","article-title":"Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study.","volume":"106","author":"Bradley","year":"2012","journal-title":"Br J Cancer"},{"key":"R30-15-20210212","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/jnci\/93.12.937","article-title":"Helicobacter pylori seropositivity as a risk factor for pancreatic cancer.","volume":"93","author":"Stolzenberg-Solomon","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R31-15-20210212","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/ijc.24936","article-title":"Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation.","volume":"126","author":"Tramacere","year":"2010","journal-title":"Int J Cancer"},{"key":"R32-15-20210212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/oxfordjournals.epirev.a036294","article-title":"Alcohol and pancreatic cancer. Insufficient epidemiologic evidence for a causal relationship.","volume":"8","author":"Velema","year":"1986","journal-title":"Epidemiol Rev"},{"issue":"9","key":"R33-15-20210212","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-111-9-738","article-title":"Risk for colorectal adenocarcinoma in pernicious anemia. A population based cohort study.","volume":"111","author":"Talley","year":"1989","journal-title":"Ann Intern Med"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000000054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:21:33Z","timestamp":1746148893000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201404000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000000054","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}